Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393525 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cyclin G2 (CCNG2) (AA 1-345) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-345
- Isotype
- IgG
- Antibody clone number
- 1F9-C11
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references An approach based on a genome-wide association study reveals candidate loci for narcolepsy.
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.
Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.
Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, Tokunaga K
Human genetics 2010 Oct;128(4):433-41
Human genetics 2010 Oct;128(4):433-41
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.
Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, Fridley BL, Ovarian Cancer Association Consortium., Gentry-Maharaj A, Menon U, Hogdall E, Kjaer S, Whittemore A, DiCioccio R, Song H, Gayther SA, Ramus SJ, Pharaoh PD, Goode EL
British journal of cancer 2009 Oct 20;101(8):1461-8
British journal of cancer 2009 Oct 20;101(8):1461-8
Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG, Noh JH, An JY, Hong SK, Park SB, Baik YH, Kim KM, Sohn TS, Kim S
The Journal of surgical research 2009 Dec;157(2):168-74
The Journal of surgical research 2009 Dec;157(2):168-74
Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.
Xu G, Bernaudo S, Fu G, Lee DY, Yang BB, Peng C
Molecular biology of the cell 2008 Nov;19(11):4968-79
Molecular biology of the cell 2008 Nov;19(11):4968-79
Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Kasukabe T, Okabe-Kado J, Honma Y
Cancer science 2008 Aug;99(8):1693-8
Cancer science 2008 Aug;99(8):1693-8
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunofluorescence of to CCNG2 on HeLa cell .